Advances in immunotherapy for the treatment of glioblastoma

por Tivnan, Amanda, Heilinger, Tatjana, Lavelle, Ed C., Prehn, Jochen H. M.
Publicado 2016

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

por Tivnan, Amanda, Tracey, Lorraine, Buckley, Patrick G, Alcock, Leah C, Davidoff, Andrew M, Stallings, Raymond L
Publicado 2011

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

por Tivnan, Amanda, Zakaria, Zaitun, O'Leary, Caitrín, Kögel, Donat, Pokorny, Jenny L., Sarkaria, Jann N., Prehn, Jochen H. M.
Publicado 2015

System-based approaches as prognostic tools for glioblastoma

por Salvucci, Manuela, Zakaria, Zaitun, Carberry, Steven, Tivnan, Amanda, Seifert, Volker, Kögel, Donat, Murphy, Brona M., Prehn, Jochen H. M.
Publicado 2019

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2

por Foley, Niamh H, Bray, Isabella M, Tivnan, Amanda, Bryan, Kenneth, Murphy, Derek M, Buckley, Patrick G, Ryan, Jacqueline, O'Meara, Anne, O'Sullivan, Maureen, Stallings, Raymond L
Publicado 2010

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance...

por Tivnan, Amanda, Heilinger, Tatjana, Ramsey, Joanne M, O’Connor, Gemma, Pokorny, Jenny L, Sarkaria, Jann N, Stringer, Brett W, Day, Bryan W, Boyd, Andrew W, Kim, Ella L, Lode, Holger N, Cryan, Sally-Ann, Prehn, Jochen H.M
Publicado 2017

Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD(2) Coated Nanoparticles

por Tivnan, Amanda, Orr, Wayne Shannon, Gubala, Vladimir, Nooney, Robert, Williams, David E., McDonagh, Colette, Prenter, Suzanne, Harvey, Harry, Domingo-Fernández, Raquel, Bray, Isabella M., Piskareva, Olga, Ng, Catherine Y., Lode, Holger N., Davidoff, Andrew M., Stallings, Raymond L.
Publicado 2012